I'm cautious about Novo Nordisk's short-term prospects due to the recent selloff, but see long-term potential with high ...

On Tuesday, New York Governor Kathy Hochul announced a new initiative to expand access to healthcare coverage for popular ...

With the holidays past and the new year arrived, we look ahead — to losing weight. For some that resolve theoretically ...

Shares of Novo Nordisk NVO gained 2.8% on Wednesday likely because the analysts at UBS upgraded the company’s rating from ...

Eli Lilly and Company’s LLY shares declined 13.5% in the past three months. Though demand for its popular tirzepatide drugs, ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 489.81% and ...

This year saw rising interest in weight-loss drugs like Ozempic, Wegovy and Zepbound. These drugs contain semaglutide, tirzepatide and other molecules that make people feel less hungry and often ...

The most significant development this year was semaglutide-based injectable weight loss drugs such as Ozempic and Wegovy. This new generation of drugs are very effective and have been a game ...

WHAM! remain strong at Number 1 with Last Christmas, celebrating the song’s 10th total week at the top of the Official Singles Chart. Last week, George Michael & Andrew Ridgeley’s pensive ...

With the Christmas posts, Musk has now shared publicly that he has tried Mounjaro, Ozempic and Wegovy, another treatment from Novo Nordisk. You may not be a billionaire like Elon Musk, but you can ...

Take a tour through the best charts 538 made this year. The year 2024 was one for the history books, and 538's visual journalists and reporters were hard at work explaining the data behind the ...

Especially one that was brimming with change and upheaval? In the face of such an impossible task, let us make a humble proposal: charts. Explore HBR HBR Store About HBR Manage My Account Follow ...